Marion Eveillard, Alexandre Desjonqueres. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AgedAntibiotics, Antineoplastic/therapeutic useAntigens, CD/analysisAntimetabolites, Antineoplastic/therapeutic useAsthenia/complicationsAzacitidine/therapeutic useBasophils/pathologyBone Marrow/pathologyCytarabine/therapeutic useFemaleHumansIdarubicin/therapeutic useLeukemia, Basophilic, Acute/bloodLeukemia, Basophilic, Acute/complicationsLeukemia, Basophilic, Acute/drug therapyLeukemia, Basophilic, Acute/pathologyLeukemia, Myeloid, Acute/complicationsLeukemia, Myeloid, Acute/drug therapy
Substances： See more » Antibiotics, AntineoplasticAntigens, CDAntimetabolites, AntineoplasticCytarabineAzacitidineIdarubicin
Year: 2014 PMID： 24949509 DOI： 10.1182/blood-2014-02-555698
Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113